title: Leptin receptor (Lepr) is a negative modulator of bone mechanosensitivity and genetic variations in Lepr may contribute to the differential osteogenic response to mechanical stimulation in the C57BL/6J and C3H/HeJ pair of mouse strains.
abstract: This study investigated the role of leptin receptor (Lepr) signaling in determining the bone mechanosensitivity and also evaluated whether differences in the Lepr signaling may contribute to the differential osteogenic response of the C57BL/6J (B6) and C3H/HeJ (C3H) pair of mouse strains to mechanical stimuli. This study shows that a loading strain of ∼2,500 με, which was insufficient to produce a bone formation response in B6 mice, significantly increased bone formation parameters in leptin-deficient ob(-)/ob(-) mice and that a loading strain of ∼3,000 με also yielded greater osteogenic responses in Lepr-deficient db(-)/db(-) mice than in wild-type littermates. In vitro, a 30-min steady shear stress increased [(3)H]thymidine incorporation and Erk1/2 phosphorylation in ob(-)/ob(-) osteoblasts and db(-)/db(-) osteoblasts much greater than those in corresponding wild-type osteoblasts. The siRNA-mediated suppression of Lepr expression in B6 osteoblasts enhanced (but in osteoblasts of C3H (the mouse strain with poor bone mechanosensitivity) restored) their anabolic responses to shear stress. The Lepr signaling (leptin-induced Jak2/Stat3 phosphorylation) in C3H osteoblasts was higher than that in B6 osteoblasts. One of the three single nucleotide polymorphisms in the C3H Lepr coding region yielded an I359V substitution near the leptin binding region, suggesting that genetic variation of Lepr may contribute to a dysfunctional Lepr signaling in C3H osteoblasts. In conclusion, Lepr signaling is a negative modulator of bone mechanosensitivity. Genetic variations in Lepr, which result in a dysfunctional Lepr signaling in C3H mice, may contribute to the poor osteogenic response to loading in C3H mice.
authors.affiliation: Musculoskeletal Disease Center, Jerry L Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California 92357, USA.
authors.forename: Sonia
authors.initials: S
authors.lastname: Kapur
authors.forename: Mehran
authors.initials: M
authors.lastname: Amoui
authors.forename: Chandrasekhar
authors.initials: C
authors.lastname: Kesavan
authors.forename: Xiaoguang
authors.initials: X
authors.lastname: Wang
authors.forename: Subburaman
authors.initials: S
authors.lastname: Mohan
authors.forename: David J
authors.initials: DJ
authors.lastname: Baylink
authors.forename: K-H William
authors.initials: KH
authors.lastname: Lau
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D001842:Bone and Bones / Q000737:chemistry / Q000378:metabolism*; D002478:Cells, Cultured; D015536:Down-Regulation; D014644:Genetic Variation; D008297:Male; D040542:Mechanotransduction, Cellular; D051379:Mice / Q000235:genetics / Q000378:metabolism*; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D010006:Osteoblasts / Q000378:metabolism*; D010012:Osteogenesis; D020641:Polymorphism, Single Nucleotide; D054411:Receptors, Leptin / Q000235:genetics* / Q000378:metabolism*; D033081:Shear Strength; D013314:Stress, Mechanical
chemical_list: D054411:Receptors, Leptin